Total Payments
$3,915
2024 Payments
$243.39
Companies
18
Transactions
152
Medicare Patients
4,023
Medicare Billing
$320,400
Payment Breakdown by Category
Food & Beverage$3,556 (90.8%)
Education$358.93 (9.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,556 | 148 | 90.8% |
| Education | $358.93 | 4 | 9.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $863.05 | 43 | $0 (2024) |
| ABBVIE INC. | $860.15 | 30 | $0 (2024) |
| Janssen Biotech, Inc. | $655.76 | 30 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $346.95 | 3 | $0 (2018) |
| Allergan Inc. | $244.86 | 3 | $0 (2018) |
| PFIZER INC. | $223.22 | 12 | $0 (2022) |
| Lilly USA, LLC | $172.42 | 6 | $0 (2022) |
| LEO Pharma Inc. | $121.14 | 8 | $0 (2022) |
| Genentech USA, Inc. | $85.83 | 4 | $0 (2022) |
| Galderma Laboratories, L.P. | $85.37 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $243.39 | 7 | Janssen Biotech, Inc. ($141.91) |
| 2023 | $268.48 | 11 | Janssen Biotech, Inc. ($143.62) |
| 2022 | $699.26 | 28 | Novartis Pharmaceuticals Corporation ($244.29) |
| 2021 | $436.10 | 20 | AbbVie Inc. ($183.28) |
| 2020 | $331.81 | 9 | Novartis Pharmaceuticals Corporation ($185.95) |
| 2019 | $707.85 | 33 | Novartis Pharmaceuticals Corporation ($362.81) |
| 2018 | $923.60 | 37 | Janssen Scientific Affairs, LLC ($224.05) |
| 2017 | $304.40 | 7 | Janssen Scientific Affairs, LLC ($122.90) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Immunology | ||||||
| 09/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Immunology | ||||||
| 06/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Immunology | ||||||
| 06/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Immunology | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.68 | General |
| 03/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 02/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Immunology | ||||||
| 10/19/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Immunology | ||||||
| 08/01/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Immunology | ||||||
| 05/18/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Dermatology | ||||||
| 05/09/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: Immunology | ||||||
| 05/01/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $122.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2022 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: BioOncology | ||||||
| 11/03/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,028 | 1,604 | $396,395 | $82,311 |
| 2022 | 11 | 1,098 | 1,768 | $411,465 | $87,238 |
| 2021 | 14 | 1,041 | 1,587 | $381,182 | $88,908 |
| 2020 | 14 | 856 | 1,257 | $261,417 | $61,942 |
Total Patients
4,023
Total Services
6,216
Medicare Billing
$320,400
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 261 | $104,400 | $25,665 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 226 | $67,800 | $14,997 | 22.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 121 | 132 | $52,800 | $9,949 | 18.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 160 | 203 | $52,780 | $8,299 | 15.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 87 | 97 | $38,800 | $8,144 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $24,300 | $4,616 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $16,000 | $3,864 | 24.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 110 | 514 | $17,990 | $2,798 | 15.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 31 | 35 | $8,750 | $1,467 | 16.8% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 18 | 19 | $7,125 | $1,274 | 17.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $4,950 | $1,156 | 23.3% |
| 87220 | Tissue fungi or parasites | Office | 2023 | 19 | 20 | $700.00 | $83.60 | 11.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 255 | 334 | $83,500 | $21,806 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 230 | $80,500 | $21,049 | 26.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 118 | 135 | $54,000 | $9,678 | 17.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 92 | 115 | $46,000 | $9,403 | 20.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 174 | 229 | $59,540 | $8,836 | 14.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 114 | 114 | $42,750 | $8,599 | 20.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 117 | 510 | $17,850 | $2,821 | 15.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 31 | 44 | $11,000 | $1,913 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $7,000 | $1,582 | 22.6% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2022 | 21 | 23 | $8,625 | $1,467 | 17.0% |
| 87220 | Tissue fungi or parasites | Office | 2022 | 18 | 20 | $700.00 | $84.18 | 12.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 170 | 271 | $91,200 | $25,976 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 219 | 280 | $66,700 | $18,401 | 27.6% |
About Dr. Eva Volf, MD
Dr. Eva Volf, MD is a Specialist healthcare provider based in Swampscott, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1124311857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eva Volf, MD has received a total of $3,915 in payments from pharmaceutical and medical device companies, with $243.39 received in 2024. These payments were reported across 152 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,556).
As a Medicare-enrolled provider, Volf has provided services to 4,023 Medicare beneficiaries, totaling 6,216 services with total Medicare billing of $320,400. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Swampscott, MA
- Active Since 05/27/2011
- Last Updated 12/16/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1124311857
Products in Payments
- COSENTYX (Biological) $662.72
- TREMFYA (Drug) $468.23
- SKYRIZI (Biological) $380.30
- Tremfya (Drug) $352.26
- EUCRISA (Drug) $223.22
- Humira (Biological) $217.53
- RINVOQ (Biological) $183.79
- TALTZ (Drug) $172.42
- KYBELLA (Biological) $138.52
- ACZONE (Drug) $106.34
- ENSTILAR (Drug) $104.63
- Erivedge (Biological) $85.83
- DUPIXENT (Biological) $72.02
- REMICADE (Biological) $59.32
- XEOMIN (Biological) $46.45
- Otezla (Drug) $42.85
- Sotyktu (Drug) $20.53
- Xeomin (Biological) $19.17
- AKLIEF (Drug) $19.10
- Enbrel (Biological) $19.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.